NVO - Novo Nordisk A/S

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 359.85B
Enterprise value 359.52B
Trailing P/E 40.70
Forward P/E 31.95
PEG Ratio (5 yr expected) 1.68
Price/sales (ttm)13.22
Price/book (mrq)30.58
Enterprise value/revenue 1.91
Enterprise value/EBITDA 4.31

Trading information

Stock price history

Beta (5Y monthly) 0.31
52-week change 340.12%
S&P500 52-week change 33.90%
52-week high 3172.97
52-week low 395.02
50-day moving average 3163.85
200-day moving average 3133.01

Share statistics

Avg vol (3-month) 31.45M
Avg vol (10-day) 31.63M
Shares outstanding 52.24B
Implied shares outstanding 6N/A
Float 812.9B
% held by insiders 10.01%
% held by institutions 18.61%
Shares short (14 May 2023) 41.56M
Short ratio (14 May 2023) 41.13
Short % of float (14 May 2023) 4N/A
Short % of shares outstanding (14 May 2023) 40.07%
Shares short (prior month 13 Apr 2023) 41.72M

Dividends & splits

Forward annual dividend rate 41.76
Forward annual dividend yield 41.11%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.90
Payout ratio 445.75%
Dividend date 303 Apr 2023
Ex-dividend date 423 Mar 2023
Last split factor 25:1
Last split date 308 Jan 2014

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 32.46%
Operating margin (ttm)43.27%

Management effectiveness

Return on assets (ttm)22.78%
Return on equity (ttm)83.50%

Income statement

Revenue (ttm)188.29B
Revenue per share (ttm)10.42
Quarterly revenue growth (yoy)27.00%
Gross profit (ttm)148.51B
Net income avi to common (ttm)61.13B
Diluted EPS (ttm)3.89
Quarterly earnings growth (yoy)39.40%

Balance sheet

Total cash (mrq)27.77B
Total cash per share (mrq)1.54
Total debt (mrq)25.52B
Total debt/equity (mrq)31.95
Current ratio (mrq)0.86
Book value per share (mrq)4.44

Cash flow statement

Operating cash flow (ttm)85.12B
Levered free cash flow (ttm)57.8B